Government. Support from regulatory bodies for using Real World Evidence Solutions (RWE) and an increase in R&D spending are anticipated to boost market growth. RWD provides supporting evidence for diseases with small size populations and rare cancers. 9.4 HEALTHCARE PROVIDERS Furthermore, it would enable the company to bring new therapies to market by leveraging these studies.Sep-2018: PAREXEL came into partnership with Datavant, a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets. For instance, in May 2020, PAREXEL International Corporation (U.S.) launched the #KeepingPatientsFirst integrated real-world evidence (RWE) research platform focused on aggregating, analyzing, and predicting real-world COVID-19-related disease progression and outcomes using state-of-the-art machine learning, artificial intelligence, and analytics. United States Real-World Evidence (RWE) Solutions Market Report 2022: Market is Expected to Grow at a CAGR of 13% from 2021 to 2028 to Reach $2.01 Billion by 2028 - ResearchAndMarkets.com March 11 . With this partnership, the company aimed at expanding Parexels network of real-world data (RWD) sources to deliver drug development solutions for customers. FIGURE 27 ECOSYSTEM COVERAGE: PARENT MARKET (HEALTHCARE IT SOLUTIONS) 10.5 LATIN AMERICA 2.1.1.1 Key data from secondary sources U.S. ,5002,7503,0003,5004 . 2.1.2.2 Insights from primary experts FIGURE 53 ORACLE CORPORATION: COMPANY SNAPSHOT (2021) TABLE 173 OPTUM INC.: BUSINESS OVERVIEW Some of the prominent players operating in the global RWES market are IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), SYNEOS HEALTH, INC. (U.S.) , CLARIVATE PLC (U.S.), Medpace Holdings Inc. (U.S.), Symphony Innovation, LLC (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), OracleCorporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.). TABLE 33 REAL WORLD EVIDENCE SOLUTIONS MARKET IN DRUG DEVELOPMENT AND APPROVALS, BY TYPE 20202027 (USD MILLION) Pharmaceutical and biotech companies are increasingly utilizing real-world evidence for collecting real-time post-trial information about drugs, which helps healthcare providers and researchers understand the negative reactions, side effects, and medication errors related to the drugs, thereby enabling them to control the potential harm caused by the drugs. Intraday data delayed at least . 12.1.2 IBM CORPORATION (IBM) Chart. 10.1 INTRODUCTION 8.2.5 OTHER THERAPEUTIC AREAS 6.7.3 ASIA PACIFIC TABLE 70 CANADA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) RWE helps and provides a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. TABLE 25 PATIENT-POWERED DATA SETS OFFERED BY KEY MARKET PLAYERS 8.2.3.1 Growing prevalence of neurological disorders to drive growth With this acquisition, the company aimed to strengthen its software portfolio through automation, data, and AI in order to address the full spectrum of observability.Nov-2021: PerkinElmer unveiled PKeye, a workflow monitor platform for remotely managing and monitoring workflows. The listing agent for these homes has added a Coming Soon note to alert buyers in advance. The increasing prevalence of chronic diseases, stringent regulations for drug approvals, implementation of the 21st Century Cures Act, availability of electronic datasets, advanced healthcare industry, and rising big data in healthcare are the major factors responsible for the largest market share of North America. 7.3.2.1 Increasing demand for integrated data from multiple sources to drive growth The report presents a detailed assessment of the real world evidence solutions market, along with qualitative inputs and insights from MarketsandMarkets. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. Note 2: Other primaries include sales managers, marketing managers, and product managers. 6.4.4 THREAT OF SUBSTITUTES 5.2.1.5 Support from regulatory bodies for the use of RWE solutions 11.4 MARKET RANKING ANALYSIS 5.2.4.2 Shortage of skilled professionals, 6 INDUSTRY INSIGHTS (Page No. TABLE 179 ORACLE CORPORATION: BUSINESS OVERVIEW TABLE 17 DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 13.5 AUTHOR DETAILS. Global Real World Evidence Solutions Market Size, Share & Trends Analysis Report by Component (Services, Data Sets), by Application, by End-user, by . 5.2.2 RESTRAINTS As a result, the demand for RWE services is higher in comparison to RWE data sets. FIGURE 18 JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 This is a record-breaking level of inflows, which raises the question: what are investors buying? Majority of institutions are currently installing software and tools to store data at their own premises due to ease of access and security, resulting in the large market share of this type of delivery. TABLE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET IN CLINICAL AND REGULATORY DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION), 9 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER (Page No. 10.3.6 REST OF EUROPE The GDS software can easily be integrated on Android, iOS, and Web platforms. TABLE 126 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) FIGURE 26 INTERNAL VS. OUTSOURCED RWE ANALYTICS APPROACH Real-world data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. A five-year forecast of the market and noted trends. 6.1.3 RISE IN THE USE OF RWD AND RWE ACROSS THE PHARMACEUTICAL INDUSTRY Science and Research Special Topics, Recalls, Market Withdrawals and Safety Alerts, Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products, Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products, Framework for FDAs Real-World Evidence Program, Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products, Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products, Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products, Data Standards for Drug and Biological Product Submissions Containing Real-World Data, Submitting Documents Utilizing Real-World Data and Real-World Evidence to FDA for Drugs and Biologics, Use of Electronic Health Records in Clinical Investigations, Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Forecasts show that the market will grow from $14.9 billion to $17.6 billion in 2024. TABLE 52 NORTH AMERICA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 1.5 Global Market Size of Real World Evidence Solutions (2017-2027) . 7500+ companies worldwide approach us every year for their revenue growth initiatives. R&D is very important in the pharmaceutical business in particular. Domain News - Provides the latest real estate and property market news in Australia. 5.2.4.1 Lack of universally accepted methodology standards and data processing infrastructure How to Determine Market Size To calculate your market size, you'll either be looking for data on the number of potential customer, or number of transactions each year. FIGURE 55 SAS INSTITUTE: COMPANY SNAPSHOT (2021) This data holds potential to allow us to better design and conduct clinical trials and studiesin the health care setting to answer questions previously though infeasible. - 98) 10.4.2.1 Low cost of clinical trials and large pharmaceutical R&D base in China to drive market growth To know about the assumptions considered for the study, download the pdf brochure. To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Two prominent healthcare data science firms, Aetion and HealthVerity, were discovered partnering in 2020, strengthening their already established partnership to extract practical medical evidence from EHRs (electronic health records) and counsel drug producers and authorities on COVID-19 treatments.Market Growth FactorsRising investment in R&D to create new goods and medical devices along with lowering the price of medication developmentMost biopharmaceutical, pharmaceutical, and medical device businesses continue to make significant investments in creating new medications and equipment. If you are an admin, please authenticate by logging in again. 8.2 DRUG DEVELOPMENT AND APPROVALS Big data comprises large data volumes, the size of which (petabytes and exabytes) exceeds the capacity of commonly employed software tools to purchase, manage and process data, over time. FIGURE 14 RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) to incorporate the statistic into your presentation at any time. [Online]. For example, although payers have begun employing RWE, they opt to use internal observational data from randomized clinical trials (RCTs) to influence drug coverage choices. 7.3.1.1 Clinical settings data set TABLE 16 DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) Thus, stakeholders are reluctant to utilise evidence lacking a standard data generation procedure. ET The 21st Century Cures Act helped accelerate medical product development and brought innovations, and expanded the role of real-world evidence in the U.S. You need a Statista Account for unlimited access. TABLE 156 LATIN AMERICA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Real-world data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. 80% of fortune 2000 companies rely on our research to identify new revenue sources. TABLE 90 UK: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 22 CLAIMS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) Thus, the key players in the RWES market are focusing on organic & inorganic growth strategies, which will help them increase their market shares in the coming years. TABLE 99 FRANCE: RWE MARKET, BY END USER, 20202027 (USD MILLION) The global Real World Evidence Solutions Market size was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031. Education. Data monetization is the sharing of data between companies. A series of well-publicized recalls, and regulatory settlements have left policymakers and consumers questioning the safety of medical products and their trust in manufacturers. TABLE 177 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 12.1.12 AETION INC. Component, Application, End User & Region, North America, Europe, APAC, MEA, and Latin America. TABLE 7 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING Show publisher information Note 3: Companies are classified into tiers based on their total revenue. In August 2022, Trinity Life Sciences (US), announced a partnership with Bain & Company (US). TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET This is because pharmaceuticals and biotech companies are becoming more aware of the potential value of RWE in life-cycle management and drug development, as well as how it can lower the cost of clinical trials and boost innovation efficiency.COVID-19 Impact AnalysisThe infectious coronavirus could economically impact most industries, including the pharmaceutical sector. TABLE 93 FRANCE: MACROECONOMIC INDICATORS TABLE 145 INDIA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 160 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 118 REST OF EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The third table is a tabulation of the CIA World Factbook GDP (PPP) data update of 2019. 5.2.4 CHALLENGES TABLE 59 US: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 97 FRANCE: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) Information about your device and internet connection, like your IP address, Browsing and search activity while using Yahoo websites and apps. TABLE 35 DRUG DEVELOPMENT AND APPROVALS MARKET IN ONCOLOGY, BY COUNTRY, 20202027 (USD MILLION) 8.5.1 GROWING USE OF RWE SOLUTIONS TO DEVELOP ECONOMIC AND BUDGET IMPACT MODELS TABLE 140 CHINA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 24*7 real-time access to a vast global inventory of hotel rooms, cars, airlines, buses, tours and other travel-related items. 11.6 COMPANY FOOTPRINT RWE can be produced through various study designs or analyses, including but not . The major reason for this preference is the presence of multiple standards and methods for analysing real-world clinical experience evidence. FIGURE 58 CLINIGEN: COMPANY SNAPSHOT (2021) Further, with the spread of the COVID-19 pandemic, immediate and long-term consequences have been both for people and health systems worldwide. FIGURE 50 SYNEOS HEALTH INC.: COMPANY SNAPSHOT (2021) TABLE 189 VERANTOS INC.: BUSINESS OVERVIEW FIGURE 22 RWE SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES Who will be your Top Customer; what will make them switch? 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY (Page No. TABLE 31 INTEGRATED DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION), 8 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION (Page No. At USD 4.6 trillion this was an increase of 12.9% from 2020. The real-world data (RWD) market is expected to grow at a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029. FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE 2.6 RISK ASSESSMENT TABLE 102 ITALY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) - 41) 10.3.4.1 The demand for RWE in Italy is high due to the widespread use of pay-for-outcomes RWE will be increasingly used to fast track drug approvals In 2016, the 21st Century Cures Act was signed into law. The Americas contributed 40.2% of the overall market size estimate. Sign up today for your free Reader Account. Sep 8, 2022 The total amount of data created, captured, copied, and consumed globally is forecast to increase rapidly, reaching 64.2 zettabytes in 2020. Find out more about how we use your information in our privacy policy and cookie policy. REDDING, Calif., March 10, 2022 /PRNewswire/ -- According to a new market research report titled "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028", published by Meticulous Research, the Real-World Evidence (RWE) solutions market is expected to grow at a CAGR of 11.8% from 2021 to 2028 to reach $4.4 billion by 2028. Get full access to all features within our Business Solutions. TABLE 48 RWE SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 20202027 (USD MILLION) FIGURE 1 RESEARCH DESIGN Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Market forecast and expert KPIs for 600+ segments in 150+ countries, Insights on consumer attitudes and behavior worldwide, Business information on 60m+ public and private companies, Detailed information for 35,000+ online stores and marketplaces. FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION Randomized, observational, interventional, and real-world- Whats in a name? (IDC, 2020) AR/VR Spending 2020 By Segment. TABLE 84 GERMANY: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 30 INTEGRATED DATA SETS OFFERED BY KEY MARKET PLAYERS Following a detailed secondary and primary research and an in-depth . 2.1.1 SECONDARY DATA 11.6.2 PRODUCT FOOTPRINT OF COMPANIES Our real world data product includes more than 300 million longitudinal covered lives, 2 million healthcare providers and 98% of payers in the United States, with visibility into more than 120 million linked claims and electronic health records (EHR). Businesses require robust evidence lifecycle management skills to demonstrate value. TABLE 138 CHINA: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) The size of the professionally managed real estate market also continued to grow in 2021, rising to USD 11.4 trillion from USD 10.5 trillion in 2020. RWD can come from a number of sources, for example: Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD. 10.2.1 US Since their creation in 1960, REITs have . Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:https://www.meticulousresearch.com/speak-to-analyst/cp_id=4954. TABLE 154 LATIN AMERICA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 6.5.2 HCIT EXPENDITURE/PRICING ANALYSIS - 198) It also helps generate broader scientific evidence and commercial insights, valuable for the pharmaceutical industry. Similarly, new solution launches & enhancements were the second most preferred strategy after partnerships, collaborations, and agreements in the market. In December 2021, TriNetX LLC announced the launch of Diversity Lens, an analytic feature that enables healthcare and life sciences organizations to make use of real-world data to comprehend and address racial and ethnic differences in clinical trial patient participation. . 10.4.1 JAPAN 12.1.1 IQVIA HOLDINGS INC. 12.1.15 PERKINELMER INC. 11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 2.1.2.1 Key data from primary sources In 2021, the pharmaceutical, biotechnology, and medical device companies segment accounted for the largest share of the overall real-world evidence solutions market. The health care community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. (Business Overview, Products, Recent Developments, MnM View)* Through this acquisition, the company would focus on developing drugs by using data, applying techniques, and identifying a variety of patient populations.Dec-2020: Syneos Health completed the acquisition of Illingworth Research Group, a provider of clinical research home health services. TABLE 62 US: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) FIGURE 9 DATA TRIANGULATION METHODOLOGY Congress defined RWE as data regarding the usage, or the potential benefits or risks, of a drug derived from sources other than traditional clinical trials. 11.8.1 PROGRESSIVE COMPANIES Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, Real-World Evidence (RWE) Solutions Market, https://www.meticulousresearch.com/download-sample-report/cp_id=4954, https://www.meticulousresearch.com/speak-to-analyst/cp_id=4954, https://www.meticulousresearch.com/Checkout/71850364, https://www.meticulousresearch.com/product/real-world-evidence-solutions-market-4954, https://www.meticulousresearch.com/custom-research, https://www.linkedin.com/company/meticulous-research, https://www.meticulousresearch.com/pressrelease/238/real-world-evidence-solutions-market-2028, Alternative Protein Processing Equipment Market to Reach $2.2 billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research, Cybersecurity Services Market Worth $158.4 Billion by 2030: Market Sizes, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research, Market Access & Reimbursement/Coverage Decisions, Pharmaceutical, Biotechnology, and Medical Device Companies. As of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =. - 81) 11.8.4 DYNAMIC COMPANIES 7.3.1.1.1 Increasing utilization of EHR data for trial recruitment to fuel growth 5.1 INTRODUCTION 12.1.10 ELEVANCE HEALTH 4.5 RWE SOLUTIONS MARKET: DEVELOPED VS. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. TABLE 82 GERMANY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Coming Soon listings are homes that will soon be on the market. 8.5 MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING 5 Introduction Randomized and observational. The .gov means its official.Federal government websites often end in .gov or .mil. 12.1.14 TRINITY LIFE SCIENCES TABLE 143 INDIA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) This growth in R&D expenditure, fueled by the need for numerous preclinical and clinical services during the drug development process, is expected to drive the growth of the real world evidence solutions market. As of December 1, 2022, there was nearly one job opening for every active applicant on LinkedIn. 10.3.4 ITALY 6.7 REGULATORY BODIES, GOVERNMENTS, AND OTHER ORGANIZATIONS Many pharmaceutical, biotechnology & medical device companies aspire to join the fight against COVID-19 by applying human data science to support research activities related to health system issues in collaboration with the world's leading academic researchers. Northern Virginia, the largest data center market in the world, encountered an unprecedented multi-year pause on development in certain submarkets, as utility companies work to address a massive . This insight, in clinical settings, can be gained by combining data from randomized controlled trials with evidence from real-world settings.Regional OutlookBased on Region, the Real World Evidence Solutions Market is segmented into North America, Europe, Asia Pacific, and LAMEA. For instance, in April 2020, ICON plc (Ireland) signed a three-year agreement with Pfizer Inc. (U.S.), under which ICON provides expertise in the planning, execution, management, and conduct of clinical trials. FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RWE SOLUTIONS, 20162021 9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE DEMAND 10.3.5.1 Rising R&D expenditure to propel market growth in Spain FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS TABLE 187 CLINIGEN: BUSINESS OVERVIEW 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION Access to this and all other statistics on 80,000 topics from, Show sources information As a Premium user you get access to the detailed source references and background information about this statistic. 4.3 RWE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES TABLE 14 RWE SERVICES MARKET, BY COUNTRY, 20202027 (USD MILLION) FIGURE 46 IQVIA HOLDINGS INC: COMPANY SNAPSHOT (2021) 12.2.1 HEALTHVERITY INC. FIGURE 13 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 7.2 SERVICES TABLE 169 DEALS, 20192022 It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. TABLE 15 DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 128 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Pharmaceutical companies have been looking for new ways to provide the best treatments for patients. Presently, Syneos Health, IQVIA, and ICON are providing late-phase services like research planning, protocol development, clinical study management & reporting, as well as endwise real-world evidence (RWE) solutions. Currently, the number of real-world evidence trials has increased for 2021.
Jade Protocol Staking,
Dumbledore's Welcome Speech Goblet Of Fire,
Articles R